Brunei vs Chile: Cause of death, by non-communicable diseases, ages 0-4, female
Brunei
49.5%
in 2021
Chile
48.9%
in 2021
Brunei rank
12th
Chile rank
15th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Brunei
- Chile
How they compare
Brunei currently reports 49.5% against 48.9% in Chile, a difference of 0.6%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Brunei ahead.
Brunei ranks 12th and Chile ranks 15th of 185 countries.
Brunei has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.5% | 43.1% | 1.5% | Brunei |
| 2010s | 51.2% | 47.5% | 3.7% | Brunei |
| 2020s | 49.5% | 48.6% | 0.8% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Brunei or Chile?
- Brunei, at 49.5% against 48.9% in Chile as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Brunei and Chile?
- 0.6%, with Brunei ahead.
- How many years of comparable data are there for Brunei and Chile?
- 6 years are reported by both, from 2000 to 2021.
- How do Brunei and Chile rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Brunei ranks 12th and Chile ranks 15th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.